Last year, Johnson & Johnson arrived late to the party with Imaavy as the third FcRn blocker approved since 2021 to treat ...

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies ...

A MAN who was paralysed by a rare autoimmune disorder stunned doctors by learning to walk again after a world-first plasma ...

A man who was paralysed from the neck down by a rare autoimmune disorder defied doctors by “proudly” walking out of hospital ...

MOG antibody-associated disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients contains antibodies against myelin oligodendrocyte glycoprotein (MOG), a ...

According to the Mayo Clinic, the condition involves the hardening and tightening of the skin, and there is no cure.

A 37-year-old woman developed an exceptionally rare cluster of neurologic autoimmune disorders with antibody-confirmed myasthenia gravis (MG), neuromyelitis optica (NMO), and anti-N-methyl-D-aspartate ...

Johnson & Johnson (NYSE:JNJ) has announced positive findings from its Phase 2/3 ENERGY clinical trial, with IMAAVY ...

Ultomiris is a brand-name biologic medication prescribed for certain rare autoimmune disorders. Dosing of Ultomiris is done via intravenous (IV) infusions administered by a healthcare professional.

When Elvis died of a heart attack brought about by high blood pressure, coronary heart disease, and prescription drug misuse, ...